Get all your news in one place.
100's of premium titles.
One app.
Start reading
StockNews.com
StockNews.com
Business
Riddhima Chakraborty

1 No-Brainer Stock to Buy When the Market Plunges

CVS Health Corporation (CVS) recently raised its adjusted EPS guidance range to $8.55 to $8.65 from $8.40 to $8.60. Moreover, it surpassed revenue estimates by 5.7% and EPS estimates by 7.9% for the 2022 third quarter.

“We continue to execute on our strategy with a focus on expanding capabilities in health care delivery, and the announced acquisition of Signify Health will further strengthen our engagement with consumers,” Karen S. Lynch, CVS’ CEO, said.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.